Moderna (MRNA) PT Raised to $68 at Roth Capital
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $63.32 -0.52%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
Roth Capital analyst Yasmeen Rahimi raised the price target on Moderna (NASDAQ: MRNA) to $68.00 (from $41.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- TKH Group NV (TWEKA:NA) PT Raised to EUR68.50 at Berenberg
- Salvatore Ferragamo SpA (SFER:IM) (SFRGY) PT Raised to EUR10.90 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
